Cancer Institute A national cancer institute
designated cancer center

Need assistance? Contact the Stanford Cancer Clinical Trials Office at 650-498-7061 or

Ofrecemos Asistencia en Español.

Search all open clinical trials at Stanford online.

New mobile clinical
trial search app!

iTunes | Google Play

Are you thinking of entering a clinical trial? Learn more here.

Español | 中文 | Pусский

View stories from Cancer Clinical Trial participants at Stanford.

Español | 中文 | Pусский


A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer

The purpose of this study is to see if adding veliparib and/or carboplatin to standard neoadjuvant chemotherapy can help shrink TNBC faster, and lower the risk of the cancer coming back in other parts of the body.

Stanford Medicine Resources:

Footer Links: